SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med 2000;342: 31419.
  • 2
    Dam M, Ekberg R, Loyning Y, et al. A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy. Epilepsy Res 1989;3: 706.
  • 3
    Brodie MJ, Richens A, Yuen AWC, et al. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. Lancet 1995;345: 4769.
  • 4
    Christe W, Kramer G, Vigonius V, et al. A double-blind, controlled clinical trial of oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy. Epilepsy Res 1997;26: 45160.
  • 5
    Bill PA, Vigonius V, Pohlmann H, et al. A double-blind controlled trial of oxcarbazepine versus phenytoin in adults with previously treated epilepsy. Epilepsy Res 1997;27: 195204.
  • 6
    Guerreiro MM, Vigonius V, Pohlmann H, et al. A double-blind, controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy. Epilepsy Res 1997;27: 20513.
  • 7
    Chadwick DW, Anhut H, Greiner MJ, et al. A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. Neurology 1998;51: 12828.
  • 8
    Chadwick DW, and the Vigabatrin European Monotherapy Study Group. Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multicentre, randomised, double-blind study. Lancet 1999;354: 139.
  • 9
    Brodie MJ, Overstall PW, Giorgi L, et al. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. Epilepsy Res 1999;37: 817.
  • 10
    Chadwick DW, Liederman DB, Sauermann W, et al. Gabapentin in generalised seizures. Epilepsy Res 1996;25: 1917.
  • 11
    Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epilepsy. Epilepsia 1981;22: 489501.
  • 12
    Considerations on designing clinical trials to evaluate the place of new antiepileptic drugs in the treatment of newly diagnosed and chronic patients with epilepsy. Epilepsia 1998;39:799–803.
  • 13
    Steiner TJ, Dellaportas CI, Findley LJ, et al. Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin. Epilepsia 1999;40: 6017.
  • 14
    Bergey GK, Morris HH, Rosenfeld W, et al. Gabapentin monotherapy, I: an 8-day, double-blind, dose-controlled, multicenter study in hospitalized patients with refractory complex partial or secondarily generalized seizures. Neurology 1997;49: 73945.
  • 15
    Beydoun A, Fischer J, Labar DR, et al. Gabapentin monotherapy, II: a 26-week, double-blind, dose-controlled, multicenter study of conversion from polytherapy in outpatients with refractory complex partial or secondarily generalized seizures. Neurology 1997;49: 74652.
  • 16
    Beydoun A, Fakhoury T, Nasreddine W, et al. Conversion to high dose gabapentin monotherapy in patients with medically refractory partial epilepsy. Epilepsia 1998;39: 18893.
  • 17
    Leach JP, Girvan J, Paul A, et al. Gabapentin and cognition: a double-blind, dose-ranging, placebo-controlled study in refractory epilepsy. J Neurol Neurosurg Psychiatry 1997;62: 3736.
  • 18
    Wilson EA, Sills GJ, Forrest G, et al. High dose gabapentin in refractory partial epilepsy: clinical observations in 50 patients. Epilepsy Res 1998;29: 1616.
  • 19
    McLean MJ, Morrell MJ, Willmore LJ, et al. Safety and tolerability of gabapentin as adjunctive therapy in a large, multicenter study. Epilepsia 1999;40: 96572.
  • 20
    Kwan P, Brodie MJ. Effectiveness of first antiepileptic drug. Epilepsia 2001;42: 125560.
  • 21
    Chow SC, Liu J. Design and analysis of clinical trials. London: Wiley, 1998.